Search Nonprofits

City of Hope, an innovative biomedical research, treatment and educational institution, is dedicated to the prevention and cure of cancer and other life-threatening diseases, guided by a compassionate, patient-centered philosophy and supported by a national foundation of humanitarian philanthropy. City of Hope is dedicated to making a difference in the lives of people with cancer, diabetes and other serious illnesses. Our mission is to transform the future of health care by turning science into a practical benefit, hope into reality. We accomplish this by providing outstanding care, conducting innovative research and offering vital education programs focused on eliminating these diseases. Founded in 1913, City of Hope is one of only 41 comprehensive cancer centers in the nation, as designated by the National Cancer Institute. Our role as leaders in patient care, basic and clinical research, and the translation of science into tangible benefit is widely acknowledged. Our community includes research associates, scientists, doctors, nurses, allied health professionals, graduate students, fundraising specialists, marketing professionals, volunteers and an extensive support staff. We are united by our desire to find cures, save lives and transform the future of health. Every discovery we make and every new treatment we create gives people the chance to live longer, better and more fully. City of Hope continues to be a pioneer of patient centered care and remains committed to its tradition of exceptional care for patients, families and communities. Each day, we live out our credo: "There is no profit in curing the body, if, in the process, we destroy the soul."

Memorial Sloan-Kettering Cancer Center is dedicated to leading the fight against cancer, individually focusing on each patient and creating an impact on cancer treatment and the biomedical research agenda around the world. As one of the world's premier cancer centers, Memorial Sloan Kettering Cancer Center is committed to exceptional patient care, leading-edge research, and superb educational programs. The close collaboration between its physicians and scientists is one of its unique strengths, enabling it to provide patients with the best care available today as we work to discover more effective strategies to prevent, control, and ultimately cure cancer in the future.

As the Drug Discovery Engine for ALS, the ALS Therapy Development Institute (ALS TDI) discovers and invents ALS treatments and partners to advance them into clinical trials. It is the first and largest nonprofit biotech focused 100% on ALS research. ALS TDI incorporates all aspects of drug discovery under one roof to find treatments as quickly as possible. Located in Watertown, MA, ALS TDI employs researchers with over 300 years of combined experience and expertise across all areas of drug discovery. ALS TDI is recognized as an international leader in preclinical and translational ALS research, and partners with pharmaceutical companies and biotechs around the world. Awarded the highest nonprofit rating – four stars – on Charity Navigator, ALS TDI spends 87 cents of every dollar raised on finding effective treatments and cures for ALS.

The Foundation Fighting Blindness, Inc. is the world’s leader in providing awareness and funding that drives the research that will provide preventions, treatments and cures for people affected by retinal degenerative diseases.

Advocating for sexual and reproductive health and rights.

The Guttmacher Institute advances sexual and reproductive health and rights through an interrelated program of research, policy analysis and public education designed to generate new ideas, encourage enlightened public debate and promote sound policy and program development. The Institute’s overarching goal is to ensure the highest standard of sexual and reproductive health for all people worldwide.

Public Citizen Foundation supports the research and educational work of Public Citizen, Inc. founded in 1971 to promote consumer rights, open government, corporate responsibility, clean energy, fair trade, environmental protection, and workplace safety.

DNDi is an independent, non-profit product development partnership working to research and develop new and improved treatments for neglected diseases such as malaria, leishmaniasis, human African trypanosomiasis (sleeping sickness) and Chagas disease. Acting in the public interest, DNDi will bridge the existing R&D gaps in essential drugs for these diseases by initiating and coordinating drug R&D projects in collaboration with the international research community, the public sector, the pharmaceutical industry, and other relevant partners.

Founded in 1973, the National Foundation for Infectious Diseases (NFID) is a non-profit 501(c)(3) organization dedicated to educating the public and healthcare professionals about the causes, prevention, and treatment of infectious diseases across the lifespan.

The Methuselah Foundation is a non-profit medical charity dedicated to extending healthy human life through proven programs supported by people like you. The Foundation supports a variety of strategies that will accelerate progress toward a comprehensive cure for age-related disease, disability, and suffering. The ultimate goal of the Foundation is nothing less than to enable humans to live longer, better, and wiser, by defeating age-related disease and suffering. Supported through the private donations of individuals and organizations that share this common vision, the Foundation has become an agent of change, replacing resignation toward the suffering of aging with a new understanding of what is possible. By including a full range of near, mid, and long-term strategies within the scope of its vision, the Methuselah Foundation expects to return powerful and measurable results to its supporters within timeframes that are meaningful to them both as individuals and to society at large.

Founded in 2003, the AMD3 foundation promotes educational programming on hip and knee care, medical missionary efforts, and other charitable activities in patient and family centered care.

The American Pharmacists Association (APhA) Foundation is a trusted source of research demonstrating how pharmacists can improve health care. For over 60 years, we have consistently proven that patient health outcomes are positively impacted by pharmacists. Our mission is to improve health by inspiring philanthropy, research and innovation that advances pharmacists’ patient care services. The APhA Foundation looks to create a new medication use system where patients, pharmacists, physicians and other health care professionals collaborate to dramatically improve the cost effectiveness and quality of patient health outcomes.